IDEAYA Biosciences (IDYA) Return on Capital Employed (2019 - 2026)

IDEAYA Biosciences has disclosed Return on Capital Employed across 8 years of filings, most recently posting 18.26% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 18.26%, up 1569.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.26% (up 1569.0% YoY), and the FY2025 annual result was 15.06%, up 2384.0% from the prior year.
• Return on Capital Employed came in at 18.26% for Q1 2026 at IDEAYA Biosciences, down from 14.64% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 14.64% in Q4 2025 to a low of 37.83% in Q2 2025.
• The 5-year median for Return on Capital Employed is 20.65% (2024), against an average of 22.24%.
• Across the five-year window, Return on Capital Employed plunged 1718 bps in 2025 and soared 1569 bps in 2026, its largest moves.
• IDEAYA Biosciences' Return on Capital Employed stood at 17.0% in 2022, then sank by 40 bps to 23.83% in 2023, then slipped by 21 bps to 28.79% in 2024, then surged by 49 bps to 14.64% in 2025, then retreated by 25 bps to 18.26% in 2026.
• The last three Return on Capital Employed figures came in at 18.26% (Q1 2026), 14.64% (Q4 2025), and 19.92% (Q3 2025), per Business Quant data.